Trial Profile
Phase 1 Study of rHSA/GCSF in Neutropenia After Chemotherapy of Cancer Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2022
Price :
$35
*
At a glance
- Drugs Albumin-granulocyte colony-stimulating factor fusion protein Beijing BioFortune/Tianjin SinoBiotech (Primary)
- Indications Neutropenia
- Focus Adverse reactions
- Sponsors Tianjin SinoBiotech
- 02 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Mar 2014 New trial record